281 related articles for article (PubMed ID: 37329269)
1. Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
Megyesfalvi Z; Gay CM; Popper H; Pirker R; Ostoros G; Heeke S; Lang C; Hoetzenecker K; Schwendenwein A; Boettiger K; Bunn PA; Renyi-Vamos F; Schelch K; Prosch H; Byers LA; Hirsch FR; Dome B
CA Cancer J Clin; 2023; 73(6):620-652. PubMed ID: 37329269
[TBL] [Abstract][Full Text] [Related]
2. SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022).
García-Campelo R; Sullivan I; Arriola E; Insa A; Juan Vidal O; Cruz-Castellanos P; Morán T; Reguart N; Zugazagoitia J; Dómine M
Clin Transl Oncol; 2023 Sep; 25(9):2679-2691. PubMed ID: 37418123
[TBL] [Abstract][Full Text] [Related]
3. Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Jett JR; Schild SE; Kesler KA; Kalemkerian GP
Chest; 2013 May; 143(5 Suppl):e400S-e419S. PubMed ID: 23649448
[TBL] [Abstract][Full Text] [Related]
4. Update 2021: Management of Small Cell Lung Cancer.
Tariq S; Kim SY; Monteiro de Oliveira Novaes J; Cheng H
Lung; 2021 Dec; 199(6):579-587. PubMed ID: 34757446
[TBL] [Abstract][Full Text] [Related]
5. Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy.
Sun A; Durocher-Allen LD; Ellis PM; Ung YC; Goffin JR; Ramchandar K; Darling G
Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):658-666. PubMed ID: 30007803
[TBL] [Abstract][Full Text] [Related]
6. Small Cell Lung Cancer: Advances in Diagnosis and Management.
Chauhan AF; Liu SV
Semin Respir Crit Care Med; 2020 Jun; 41(3):435-446. PubMed ID: 32450596
[TBL] [Abstract][Full Text] [Related]
7. Initial management of small-cell lung cancer (limited- and extensive-stage) and the role of thoracic radiotherapy and first-line chemotherapy: a systematic review.
Sun A; Durocher-Allen LD; Ellis PM; Ung YC; Goffin JR; Ramchandar K; Darling G
Curr Oncol; 2019 Jun; 26(3):e372-e384. PubMed ID: 31285682
[TBL] [Abstract][Full Text] [Related]
8. Management of Small Cell Lung Cancer: Progress and Updates.
Altan M; Chiang AC
Cancer J; 2015; 21(5):425-33. PubMed ID: 26389768
[TBL] [Abstract][Full Text] [Related]
9. Cooperative group research endeavors in small-cell lung cancer: current and future directions.
Sangha R; Lara PN; Adjei AA; Baas P; Choy H; Gaspar LE; Goss G; Saijo N; Schiller JH; Vokes EE; Gandara DR
Clin Lung Cancer; 2009 Sep; 10(5):322-30. PubMed ID: 19808190
[TBL] [Abstract][Full Text] [Related]
10. Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study.
Senan S; Okamoto I; Lee GW; Chen Y; Niho S; Mak G; Yao W; Shire N; Jiang H; Cho BC
Clin Lung Cancer; 2020 Mar; 21(2):e84-e88. PubMed ID: 31948903
[TBL] [Abstract][Full Text] [Related]
11. Atezolizumab plus carboplatin and etoposide in small cell lung cancer patients previously treated with platinum-based chemotherapy.
Ishii H; Azuma K; Kawahara A; Matsuo N; Tokito T; Hoshino T
Invest New Drugs; 2021 Feb; 39(1):269-271. PubMed ID: 32783090
[TBL] [Abstract][Full Text] [Related]
12. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
Ragavan M; Das M
Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
[TBL] [Abstract][Full Text] [Related]
13. [Small cell lung cancer heterogeneity and molecular subtypes: biological and clinical relevance].
Berta J; Ferencz B; Horváth L; Fillinger J; Lantos A; Bogos K; Rényi-Vámos F; Megyesfalvi Z; Döme B
Magy Onkol; 2023 Sep; 67(3):181-192. PubMed ID: 37768117
[TBL] [Abstract][Full Text] [Related]
14. Current concepts in the management of small cell lung cancer.
Ganti AK; West WW; Zhen W
Indian J Med Res; 2013 Jun; 137(6):1043-51. PubMed ID: 23852285
[TBL] [Abstract][Full Text] [Related]
15. First-line atezolizumab/durvalumab plus platinum-etoposide combined with radiotherapy in extensive-stage small-cell lung cancer.
Li L; Yang D; Min Y; Liao A; Zhao J; Jiang L; Dong X; Deng W; Yu H; Yu R; Zhao J; Shi A
BMC Cancer; 2023 Apr; 23(1):318. PubMed ID: 37024843
[TBL] [Abstract][Full Text] [Related]
16. SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019).
Dómine M; Moran T; Isla D; Martí JL; Sullivan I; Provencio M; Olmedo ME; Ponce S; Blasco A; Cobo M
Clin Transl Oncol; 2020 Feb; 22(2):245-255. PubMed ID: 32040815
[TBL] [Abstract][Full Text] [Related]
17. Management of small-cell lung cancer: incremental changes but hope for the future.
Hann CL; Rudin CM
Oncology (Williston Park); 2008 Nov; 22(13):1486-92. PubMed ID: 19133604
[TBL] [Abstract][Full Text] [Related]
18. Current Diagnosis and Management of Small-Cell Lung Cancer.
Wang S; Zimmermann S; Parikh K; Mansfield AS; Adjei AA
Mayo Clin Proc; 2019 Aug; 94(8):1599-1622. PubMed ID: 31378235
[TBL] [Abstract][Full Text] [Related]
19. Anti-PD-L1 immune checkpoint inhibitors in combination with etoposide and platinum for extensive-stage small cell lung cancer: a case report.
Xue L; Chen B; Lin J; Peng J
Ann Palliat Med; 2021 Jan; 10(1):828-835. PubMed ID: 33545805
[TBL] [Abstract][Full Text] [Related]
20. Small-cell lung cancer.
Rudin CM; Brambilla E; Faivre-Finn C; Sage J
Nat Rev Dis Primers; 2021 Jan; 7(1):3. PubMed ID: 33446664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
